Choline Chloride for Injection
Sponsors
Protara Therapeutics Inc., Protara Therapeutics
Conditions
Choline DeficiencyIntestinal FailureLiver Injury
Phase 2
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
RecruitingNCT06910943
Start: 2025-12-10End: 2029-01-01Target: 129Updated: 2026-08-24
A Phase 2b/3 Randomized Open-Label Dose-Selection Study with Open-Label Extension and Randomized Double-Blind, Placebo-Controlled Study with Open-Label Extension to Evaluate the Safety and Efficacy of Choline Chloride for Injection (Low Dose and High Dose) Versus Placebo in Adolescents and Adults with Intestinal Failure Receiving Long-Term Parenteral Support
RecruitingCTIS2024-519496-26-00
Start: 2025-09-25Target: 117Updated: 2026-01-20